
Sitagil50 mg
Incepta Pharmaceuticals Ltd.
Sitagliptin is indicated for the following uses: Established indication: As an adjunct to diet and exercise to improve glycemic (blood sugar) control in adults with type 2 diabetes mellitus and more.
Sitagliptin is indicated for the following uses:
Sitagliptin is not indicated for type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis.
The dose of Sitagliptin is individualized based on the indication, current antidiabetic regimen, and renal function. See the dosage and administration sections below for details, and use_in_special_populations for renal dose adjustment.
Common side effects of Sitagliptin include:
Less common but serious effects that require prompt medical attention include acute pancreatitis, severe joint pain (arthralgia), skin blistering (bullous pemphigoid), and hypersensitivity reactions. See precautions_and_warnings for details.
Sitagliptin is contraindicated in patients with a history of a serious hypersensitivity reaction to Sitagliptin, such as anaphylaxis, angioedema, or severe cutaneous reactions (e.g., Stevens-Johnson syndrome).
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.